3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
17
Breast Neoplasms
17
Prostatic Neoplasms
10
Hematologic Neoplasms
9
Colorectal Neoplasms
9
Lung Neoplasms
8
Carcinoma, Non-Small-Cell Lung
6
Hematopoietic and Lymphatic System Neoplasm
5
Urinary Bladder Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Head and Neck Neoplasms
4
Anatomic Stage I Breast Cancer AJCC v8
4
Triple Negative Breast Neoplasms
3
Pancreatic Neoplasms
3
Neoplasm Metastasis
3
Mouth Neoplasms
3
Melanoma
3
Malignant Solid Neoplasm
3
Leukemia, Myeloid, Acute
3
Sarcoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Parotid Neoplasms
2
Ovarian Neoplasms
2
Oropharyngeal Neoplasms
2
Head and Neck Carcinoma
2
Glioma
2
Carcinoma, Squamous Cell
2
Carcinoma, Renal Cell
2
Carcinoma, Basal Cell
2
COVID-19
2
Interventions
gedatolisib
1
gallium 68 PSMA-11
1
darolutamide
1
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
1
(225)Ac-PSMA-617
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Genital Diseases, Male
×
Standard of Care
×
90 days
×
Clear all
No trials found.